Author: Roper, Rachel L; Rehm, Kristina E
Title: SARS vaccines: where are we? Cord-id: y4eyse0y Document date: 2014_1_9
ID: y4eyse0y
Snippet: In this review, the current state of vaccine development against human severe acute respiratory syndrome (SARS) coronavirus, focusing on recently published data is assessed. We discuss which strategies have been assessed immunologically and which have been evaluated in SARS coronavirus challenge models. We discuss inactivated vaccines, virally and bacterially vectored vaccines, recombinant protein and DNA vaccines, as well as the use of attenuated vaccines. Data regarding the correlates of prote
Document: In this review, the current state of vaccine development against human severe acute respiratory syndrome (SARS) coronavirus, focusing on recently published data is assessed. We discuss which strategies have been assessed immunologically and which have been evaluated in SARS coronavirus challenge models. We discuss inactivated vaccines, virally and bacterially vectored vaccines, recombinant protein and DNA vaccines, as well as the use of attenuated vaccines. Data regarding the correlates of protection, animal models and the available evidence regarding potential vaccine enhancement of SARS disease are discussed. While there is much evidence that various vaccine strategies against SARS are safe and immunogenic, vaccinated animals still display significant disease upon challenge. Current data suggest that intranasal vaccination may be crucial and that new or combination strategies may be required for good protective efficacy against SARS in humans.
Search related documents:
Co phrase search for related documents- absence presence and ad vaccine: 1
- accelerated vaccine initiative and acute respiratory syndrome: 1, 2
- accelerated vaccine initiative sars and acute respiratory syndrome: 1
- acute respiratory syndrome and ad vaccination: 1, 2
- acute respiratory syndrome and ad vaccine: 1, 2, 3, 4
- acute respiratory syndrome and additional advantage: 1
- acute respiratory syndrome and additional structural protein: 1
- acute respiratory syndrome and additional viral protein: 1, 2
Co phrase search for related documents, hyperlinks ordered by date